by Dr. Neil Love
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Language
🇺🇲
Publishing Since
5/30/2006
Email Addresses
0 available
Phone Numbers
0 available
April 10, 2025
<p>Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. </p><p>CME information and select publications <a href="https://www.researchtopractice.com/FirstLineTherapyALKmNSCLC24" rel="noopener noreferrer" target="_blank">here</a>. </p>
February 6, 2025
<p>Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. </p><p>CME information and select publications <a href="https://www.researchtopractice.com/YiR2024/EGFRNSCLC" rel="noopener noreferrer" target="_blank">here</a></p>
December 13, 2024
Dr Edward B Garon shares insights on integrating new lung cancer research findings into current practice, transforming patient care outcomes.
Sam and Karine
Dr. Neil Love
IASLC
Dr. Neil Love
Research To Practice
Vinay Prasad, MD MPH
Dr. Neil Love
Dr. Neil Love
Dr Neil Love
American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO)
Dr. Neil Love
Marketplace
The Wall Street Journal & Gimlet
STAT
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.